Published in Health Business Week, December 11th, 2009
The Rights Issue aims to give Tripep the financial capacity the company needs for finalizing the ChronVac-C® study and continue the clinical development of a new generation of ChronVac-C®...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.